Randall A. Lipps - 01 Dec 2025 Form 4 Insider Report for OMNICELL, INC. (OMCL)

Reporting relationship: CHAIRMAN, PRESIDENT AND CEO, Director
Issuer ticker: OMCL
Reported as of: 01 Dec 2025
Net transaction value: -$233,568
SEC form: 4
Accepted by SEC: 03 Dec 2025, 16:05:14 UTC
Prior SEC filing: 18 Nov 2025
Next SEC filing: 17 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Eric G. Lehmann, Attorney-in-Fact for Randall Lipps

Key filing fact

Randall A. Lipps filed Form 4 for OMNICELL, INC. (OMCL) on 03 Dec 2025.

Key facts

This page summarizes Randall A. Lipps's Form 4 filing for OMNICELL, INC. (OMCL).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Dec 2025, 16:05.

Change

Previous filing in this sequence was filed on 18 Nov 2025.
Current net transaction value: -$233,568.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001227556 Primary reporting owner

LIPPS RANDALL A

Relationship: CHAIRMAN, PRESIDENT AND CEO, Director
Address: OMNICELL, INC., 4220 NORTH FREEWAY, FORT WORTH
Signature: /s/ Eric G. Lehmann, Attorney-in-Fact for Randall Lipps
Signature date: 03 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OMCL transaction

Common Stock

Options Exercise

Transaction value: $782,525
Shares: +28,250
Change %: +7.3%
Price: $27.70
Shares after: 414,898
Date: 01 Dec 2025
Ownership: Direct
Footnotes: F1

OMCL transaction

Common Stock

Sale

Transaction value: $1,016,093
Shares: -28,250
Change %: -6.8%
Price: $35.97
Shares after: 386,648
Date: 01 Dec 2025
Ownership: Direct
Footnotes: F1, F2

OMCL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 355,861
Date: 01 Dec 2025
Ownership: In Trust with Wife
Footnotes: F3

OMCL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,051
Date: 01 Dec 2025
Ownership: In Trust for Children
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OMCL transaction Derivative

Stock Option NQ (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -28,250
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 28,250
Exercise price: $27.70
Footnotes: F1, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

Footnote F2

The price reported in Column 4 is a weighted average price of $35.9679. The sold price range between $35.65 to $36.4746. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

Shares held in trust with Mr. Lipps' wife.

Footnote F4

Shares held in trust for the benefit of Mr. Lipps' children.

Footnote F5

The options were granted on 2/4/2016 with 25% vested on the one-year anniversary of the grant date and the reaming amount vesting ratably over a 36 month period. The options were fully vested on 2/4/2020.